Abnoba GmbH

Integrative Oncology and Complementary Cancer Therapies

The sponsor demonstrates a focused commitment to advancing integrative oncology through the development of complementary therapeutic approaches for cancer treatment. Their research portfolio encompasses investigations into biological cancer therapies that aim to support conventional oncological interventions. The organization’s work reflects a dedication to exploring alternative pathways in cancer care, with particular emphasis on therapies derived from natural sources that may enhance patient outcomes and quality of life during cancer treatment.

  • Biological and Natural Product-Based Cancer Therapeutics
  • Supportive Care in Oncology
  • Complementary Medicine Integration

The research activities supported by this sponsor contribute to the expanding field of complementary and alternative medicine in oncology, addressing the growing clinical interest in holistic approaches to cancer management. Their investigations support the evidence base for integrative treatment strategies that combine conventional and complementary modalities.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness of Mistletoe Extract and Mitomycin in Patients with Superficial Bladder Cancer

    Not recruiting

    1 1 1 1
    Germany